These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 7878805

  • 1. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
    Königsrainer A, Aichberger C, Riedmann B, Steurer W, Ofner D, Margreiter R.
    Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 3. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 4. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N, Rodger RS, McMillan MA, Junor BJ.
    Transplantation; 2007 Mar 15; 83(5):582-7. PubMed ID: 17353778
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Mar 15; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 9. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B, Korn A.
    Transplant Proc; 1996 Aug 15; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract] [Full Text] [Related]

  • 10. Reduction of immunosuppressive therapy after renal transplantation: a randomized study.
    Heering P, Westhoff A, Ivens K, Kutkuhn B, Grabensee B.
    Transplant Proc; 1994 Oct 15; 26(5):2530-2. PubMed ID: 7940778
    [No Abstract] [Full Text] [Related]

  • 11. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan 15; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 12. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
    Vanrenterghem Y, Peeters J.
    Transplant Proc; 1996 Aug 15; 28(4):2097-9. PubMed ID: 8769165
    [No Abstract] [Full Text] [Related]

  • 13. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Aug 15; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 14. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
    Kliem V, Repp H, Frei U.
    Transplant Proc; 1994 Oct 15; 26(5):2553-5. PubMed ID: 7940788
    [No Abstract] [Full Text] [Related]

  • 15. Optimal cyclosporine therapy--an Indian experience.
    Raj DS, Somiah S, Mani K.
    J Assoc Physicians India; 1996 Jan 15; 44(1):34-6. PubMed ID: 8773092
    [Abstract] [Full Text] [Related]

  • 16. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun 15; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec 15; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 19. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
    Yun YS, Kim BJ, Hong SP, Lee TW, Lim CG, Kim MJ.
    Transplant Proc; 1996 Jun 15; 28(3):1561-4. PubMed ID: 8658786
    [No Abstract] [Full Text] [Related]

  • 20. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS, Shaheen FA, Mathew MC, Abou Zeinab HM, Al Alfi A, Tarif NM, Al Mousawi MS, Mahmoud TS, Alorrayed AS, Fagir EA, Dham RS, Shaker DS.
    Transplant Proc; 2008 Sep 15; 40(7):2245-51. PubMed ID: 18790205
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.